Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future.

Autor: Follen, Michele, Meyskens Jr., Frank L., Atkinson, E. Neely, Schottenfeld, David, Follen, M, Meyskens, F L Jr, Atkinson, E N, Schottenfeld, D
Předmět:
Zdroj: JNCI: Journal of the National Cancer Institute; 9/5/2001, Vol. 93 Issue 17, p1293-1296, 4p, 1 Chart
Abstrakt: Comments on the cervical cancer incidence among women by the World Health Organization. Factors influencing the design of cervical chemoprevention trials; Eligibility for cervical chemoprevention trials; Dose and duration of medications used in chemoprevention trials.
Databáze: Complementary Index